GPG Ventures is a venture capital firm that primarily focuses on early-stage healthcare and medical technology companies, seeking disruptive ideas with large market opportunities and strong management teams. They typically provide start-up or growth capital, often for companies completing pivotal studies of safety and effectiveness.
40% of their portfolio is in Healthcare. Their most common stage is series-b (40% of deals). Average disclosed round size is $24.8M (across 4 rounds with reported amounts).
Portfolio
5
Fund Size
—
Top Stage
Series B
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
5 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Affineon Health | Seed | $5M | Feb 2025 |
 MicroTransponder | Series E | $53M | Jun 2022 |
 Iterion Therapeutics | Series B | $17M | Feb 2021 |
 YourMechanic | Series B | $24M | Mar 2016 |
 Worlds | Series A | — | — |
Top Co-Investors
U.S. Venture Partners1 shared
Osage University Partners1 shared
Exceller Hunt Ventures1 shared
Action Potential Venture Capital1 shared
The Vertical Group1 shared
Viva BioInnovator1 shared
Moneta1 shared
Chevron Technology Ventures1 shared
Piva1 shared
Andreessen Horowitz1 shared
Lerer Hippeau1 shared
Data Point Capital1 shared
Verizon1 shared
SoftBank Vision Fund1 shared
SAIC Capital1 shared
Silicon Valley Bank1 shared
Headwater1 shared
Deepwater1 shared
BGV1 shared
Signal Peak Ventures1 shared
Last updated: 8 March 2026